GlassScriptPhysician profile
Vikram Raje
NPI 1649563255
$18,774.23
in general payments reported to CMS, 2019-2025
35 companies · $3,086 in 2025
The $3,086 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,197 · 2020: $276 · 2021: $740 · 2022: $1,303 · 2023: $3,886 · 2024: $5,286 · 2025: $3,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,150 · Travel and Lodging: $5,083 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,149.68 |
| Travel and Lodging | $5,083.36 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $5,520.83 | 2023-2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $3,518.95 | 2019 | |
| Abiomed | $2,315.04 | 2023-2025 | Impella |
| Merck Sharp & Dohme LLC | $945.97 | 2021-2025 | Verquvo, Winrevair |
| Abbott Laboratories | $807.10 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $771.03 | 2019-2025 | General - Balloon Catheters, Watchman Flx, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $709.11 | 2021-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $523.57 | 2020-2025 | Uptravi, Opsumit |
| Novo Nordisk INC | $385.35 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Impulse Dynamics (USA) INC. | $326.30 | 2022-2025 | Optimizer, Optimizer |
| E.R. Squibb & Sons, L.L.C. | $313.16 | 2022-2024 | Camzyos |
| Novartis Pharmaceuticals Corporation | $294.92 | 2021-2025 | |
| Pfizer INC. | $252.33 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $237.84 | 2020-2025 | Farxiga, Wainua, Lokelma |
| Janssen Pharmaceuticals, INC | $177.23 | 2020-2023 | Xarelto |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.59 | 2020-2025 | Jardiance |
| Bard Peripheral Vascular, INC. | $157.14 | 2019 | |
| Bridgebio Pharma, INC. | $151.91 | 2025 | Attruby |
| Inari Medical, INC. | $141.94 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $135.69 | 2023-2024 | Inpefa |
| Atricure, INC. | $133.90 | 2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Edwards Lifesciences Corporation | $126.45 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.96 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $100.82 | 2022-2025 | Amvuttra |
| Amgen INC. | $82.39 | 2022-2024 | Repatha |
| Daiichi Sankyo INC. | $73.53 | 2021-2023 | Injectafer |
| Scpharmaceuticals INC. | $59.37 | 2023-2025 | |
| Medtronic, INC. | $56.99 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $56.36 | 2023-2024 | Assure Wcd |
| Shockwave Medical, INC | $29.64 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baxter Healthcare | $23.07 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Angiodynamics, INC. | $19.62 | 2022 | |
| United Therapeutics Corporation | $19.38 | 2021 | |
| Livanova USA, INC. | $17.18 | 2023 | Lifesparc |
| Lilly USA, LLC | $16.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Raje listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.